Market Research Blog

Endoscopic Vessel Harvesting System Market Overview

With the increasing rate of cardiovascular disease constant innovation and advancement in technology has become paramount. In the field of coronary artery bypass grafting (CABG) introduction of endoscopic vessel harvesting system market trend has open up newer opportunities for companies.

Coronary artery bypass graft surgery (CABG) is a procedure for restoring the blood supply to the heart muscle due to blockage or narrowing of one or more coronary arteries. Traditionally, the technique involved in harvesting procedure was open vein harvesting (OVH) which involved a single continuous skin incision. With the recent advancement in technology, the process is less invasive by endoscopic vessel harvesting (EVH) this technique reduces leg wound morbidity because of small incisions compared to open vein harvesting.

Download Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1620

Some major companies in the endoscopic vessel harvesting system market are Maquet Holding B.V. & Co. KG., OLYMPUS CORPORATION, Terumo Cardiovascular Systems Corporation., Med Europe S.r.l. (Elite Life Care), Sorin Group Inc., Saphena Medical, Inc and Terumo Cardiovascular Systems Corporation.

• Endoscopic vessel harvesting system Market Segments
• Endoscopic vessel harvesting system Market Dynamics
• Historical Actual Market Size, 2013 – 2015
• Endoscopic vessel harvesting system Market Size & Forecast 2016 to 2026
• Endoscopic vessel harvesting system Market Current Trends/Issues/Challenges
• Competition & Companies involved
• Endoscopic vessel harvesting system Market Drivers and Restraints

Ask to Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-1620

Endoscopic Vessel Harvesting System Market

The Global endoscopic vessel harvesting system market is segmented on the basis of product type and regional presence:

Segmentation based on product type

• Disposable
• Reusable

Geographically the endoscopic vessel harvesting system market is segmented into five key regions

• North America
• Latin America
• Europe
• Asia Pacific
• MEA region

The endoscopic vessel harvesting system market in Asia Pacific is expected to deliver tremendous growth due to the growth in per capita income in Asian countries and increase in medical tourism industry. With the growing access of public with healthcare professional and expanding economy china is expected to be the fastest growing market for endoscopic vessel harvesting system.

Key Segments in the Endoscopic Vessel Harvesting System

Segmentation based on Product Type:

• Disposable
• Reusable

By Region:

• North America
• Latin America
• Asia Pacific
• MEA
• Europe

Top Related Reports Healthcare Market Insights

https://www.scoop.it/topic/automotive-by-vishal-58/p/4136167875/2022/09/28/dermal-fillers-market-to-undertake-strapping-growth-by-the-end-2031-fmi?&kind=crawled&fId=1081630

https://odlook.com/post/5972_according-to-this-new-report-titled-dermal-fillers-market-global-industry-analys.html

https://london-news-community.tribeplatform.com/general/post/dermal-fillers-market-demand-scope-and-future-estimation-until-2031-fgEeMJF29SXiOM2

https://addandclick.com/post/269371_according-to-this-new-report-titled-dermal-fillers-market-global-industry-analys.html

https://club.vexanium.com/post/according-to-this-new-report-titled-dermal-fillers-market-global-industry-a–63344b612649cea93fcd4b7f

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Global veterinary imaging market revenues will reach US$ 3.37 Bn by 2030, according to a study by Future Market Insights (FMI). The research study analyzes veterinary imaging market growth through 2030, in over 20+ countries. The study also offers incisive insights on key strategies of some of the leading players in the market.

Veterinary Imaging Market Size (2022)	US$ 2.02 Bn
Sales Forecast (2030)	US$ 3.37 Bn
Global Market Growth Rate (2022 to 2030)	6.6% CAGR
North America Region USD Share	46.1%

According to the study, veterinary diagnostics market is witnessing investments, as pet humanization trend gains traction. Growing focus and government mandates on maintaining animal health is also likely to provide a boost to market growth.

The growth of the animal and pet care category as a whole will also spur growth. According to estimates from NAPHIA, the spending on pet food, pet insurance, and pet therapeutics have witnessed an increase in the recent past. The pet food category has in fact grown despite the Covid-19 crisis.

The broader gains in this market are likely to rub off on veterinary imaging market as well during the assessment period.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-12368

List of Key Players Covered in Veterinary Imaging market are:

• Esaote
• IDEXX Laboratories, Inc.
• IMV Technologies group
• Carestream Health
• Hallmarq Veterinary Imaging Ltd.
• MinXray, Inc.
• Universal Medical Systems, Inc.
• Agfa- Gevaert N.V.
• Mindray Medical International Ltd.
• GE Healthcare
• Siemens AG

The key market players are emphasizing on creating awareness about veterinary imaging devices to enter the untapped markets. For instance – in Oct 2018, GE Healthcare announced having inked a strategic agreement with SonoSim for encouraging training regarding ultrasound services.

Ask for Customization

https://www.futuremarketinsights.com/customization-available/rep-gb-12368

Key Takeaways

• Animal healthcare being a costly affair, people are shifting their gears to pet insurance
• The veterinary imaging market is driven by an ever-increasing number of veterinarians adopting imaging devices with reagents associated with them, which include PET, MRI, X-Ray radiology devices, and CT scanners
• Multi-slice CT scan systems expected to drive the market in the forecast period
• Asia-Pacific is slowly picking up with people turning the tide in favour of pet care
• Adoption of magnetic resonance imaging (MRI) systems continue to grow at a steady pace

Regional Insights

As per the American Pet Products Association, more than 44% of households owned dogs and 35% owned cats in the U.S. This number is expected to witness an upswing over the forecast period.

The market in China is expected to witness a considerable expansion, due to the rising awareness of veterinary imaging and the growing popularity of companion animals. The rising preference for innovative veterinary imaging systems will spur the market demand.

Veterinary Imaging Market by Region:

• North America Veterinary Imaging Market
• Latin America Veterinary Imaging Market
• Europe Veterinary Imaging Market
• East Asia Veterinary Imaging Market
• South Asia & Pacific Veterinary Imaging Market
• Middle East & Africa (MEA) Veterinary Imaging Market

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-12368

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global anatomic pathology market forecast is set to reach US$ 61.1 Mn in revenues by 2030, according to a new market study by ESOMAR-certified market research firm, Future Market Insights (FMI).

Anatomic Pathology Market Size (2022)	US$ 32.5 Mn
Anatomic Pathology Market Revenue Forecast (2030)	US$ 61.1 Mn
Anatomic Pathology Market Growth Rate (2022-2030)	8.2% CAGR
North America Market Share	37.1%

The anatomic pathology market is subject to integrating medical informatics standards to meet specific healthcare requirements by curtailing costs and improvising on efficiency.

Pathology laboratories are on the verge of refurbishment as new-fangled disease diagnostic models are making a beeline therein.

As of now, lymphoma, breast cancer, colorectal cancer, prostate cancer, cervical cancer, and lung cancer are a part of anatomic pathology.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-12370

Key Takeaways

• The instruments are subject to technological advancements, which would minimize errors. This factor is expected to drive the anatomic pathology market between 2022 and 2030
• Consumables are expected to hold the largest market share due to low cost, high availability, and good purchase rate of probes and reagents
• Academic research is bound to pick up pace in the forecast period owing to growing implementation of anatomic pathology in biomarker profiling and tumor examination
• Preference to personalized therapies is prompting putative biomarkers being discovered. This factor is expected to be one of the key growth drivers

Key Participant Insights

The key market players are focusing on technological upgradations and expansion strategies to keep themselves fiercely competitive.

For instance –

• In Jul 2020, Bio SB tabled its Fast Mohs PolyDetector Plus Detection System, which comes across as a super sensitive nonbiotin monovalent Fab micropolymer immunohistochemistry system to detect IVD antibodies for squamous cell carcinoma, basal cell carcinoma, and melanoma.
• In Jan 2019, Quest Diagnostics announced completion of acquisition of the US laboratory services business that belonged to Oxford Immunotec (the T-Spot and Accutix tick-borne disease testing services, since then, are part of Quest’s infectious disease testing services.
• In 2018, Leica Microsystems entered into a collaboration with Thermo Fisher to develop an integrated cryotomography workflow with regards to research.

Ask for Customization

https://www.futuremarketinsights.com/customization-available/rep-gb-12370

The other players in the veterinary imaging market include

• Laboratory Corporation of America Holdings
• Sakura Finetek USA, Inc.
• F.Hoffmann-La Roche AG
• Cardinal Health, Inc.
• BioGenex
• NeoGenomics
• Agilent Technologies

The US continues to be one of the leading markets for anatomic pathology market globally. Strong presence of some of the leading players, combined with relatively easier funding for R&D will drive the US anatomic pathology market during the assessment period.

The Europe anatomic pathology market is also likely to grow at a brisk pace during the assessment period. The growth will remain concentrated in Western Europe, as has been the case traditionally.

Asia Pacific represents a high growth market for anatomic pathology stakeholders. Many countries in the region are renewing their focus on healthcare, as the current Covid-19 crisis has reinforced the necessity of a robust healthcare system.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global anatomic pathology market is segmented in detail to cover every aspect and present a complete market intelligence approach to the reader.

The study provides compelling insights on anatomic pathology market on the basis of product & services type (Instruments (Microtomes & Cryostat, Tissue processors, Automatic Stainers, and Other products), consumables (Reagents & Antibodies, Probes & Kits, and Others), application (Disease Diagnosis, Drug Discovery and Development, and Others), and services (histopathology, cytopathology)) across seven geographies.

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-12370

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

According to FMI, the worldwide guidewires market demand is anticipated to reach US$ 3.3 billion in 2020 and is anticipated to grow significantly over 6.0% between 2020 and 2030. According to a recent analysis by consulting company Future Market Insights, the market for guidewires is expected to reach US $6.0 Bn by 2030. The manufacture of guidewires has increased recently as a result of the increased end-user demand for treating various ailments. Interventional radiology approaches for image-guided illness detection and treatment have become more widely used as a result of developments in guidewire tip technologies. Patient recovery results have been markedly improved by interventional radiology. This is due to the procedure’s lower risk, shorter recovery period, and less pain compared to open surgery. Vascular, gastrointestinal, hepatobiliary, and pulmonary interventions can all benefit greatly from interventional radiology.

Data Points	Market Insights
Market Value 2021	US$ 3.5 Bn
Market Value 2022	US$ 3.7 Bn
Market Value 2030	US$ 5.9 Bn
CAGR 2022-2030	6.1%
Market Share of Top 5 Countries	59.7%
Key Market Players	Boston Scientific Corporation, Terumo Corporation, Cardinal Health Inc., Cook Medical Inc., Johnson & Johnson, Medtronic PLC, Teleflex Corporation, Stryker Corporation, B. Braun Melsungen AG, Abbott Laboratories, Olympus Corporation, Merit Medical Inc. and Becton, Dickinson and Company

As the incidences of non-communicable diseases (NCDs) such as cancer, diabetes and chronic respiratory diseases continue to increase, healthcare providers are making concerted efforts to reduce their prevalence by providing sophisticated medical care. Therefore, adoption of technologically enhanced guidewires has acquired immense importance.

Over the years, minimally invasive surgeries have become highly popular, due to the need to reduce trauma. On the back of this, guidewires adoption has boomed. Guidewire engineering has transitioned towards advanced lesions such as chronic total occlusions (CTO) which are more adept at improving cardiac anomalies by improving ischemia and improve left ventricular function. Therefore, market players are introducing innovative products to cater to CTO lesions.

A minor blip is anticipated for the guidewires market from the coronavirus pandemic. Due to the imposition of lockdowns, many manufacturers are operating at reduced capacities, limiting daily output of guidewires. This has generated a significant disequilibrium in the demand-supply dynamics. This mismatch is anticipated to prevail until the last quarter of 2020 until production resumes at full capacity.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-11706

Key Takeaways from the Guidewires Market Study:

• The global guidewires market shall expand at a rate of 6.0% in 2020, driven by increased adoption of guidewires for minimally invasive coronary heart diseases
• By application, coronary and peripheral guidewires shall collectively capture over 60% of the market share during the forecast period
• Stainless steel guidewires are the most extensively used due to their high ductility, support and torque, making it the highest revenue generator by material type
• North America remains the most lucrative guidewires market, generating nearly 2/5^th of the total revenue in the market

Hand Sanitizer Market: Key Trends

• According to the World Health Organization, seven out of ten patients succumb to non-communicable diseases, especially in the low and middle income nations. This has increased the need for surgical procedures for NCDs, pushing up guidewire usage
• Interventional guidewires are experiencing increased adoption in minimally invasive surgical procedures as they reduce trauma and pain from surgical incisions.
• Majority of the guidewires demand is stimulated from the Asia-Pacific, owing to high fatalities due to diseases like cancer, diabetes, cardiac arrests and asthma.

Hand Sanitizer Market: Region-wise Analysis

• North America shall continue generating lucrative opportunities. High adoption rate of interventional and diagnostic guidewires for several diseases is a major growth accelerator
• The United States has exhibited significant consistency in showing notable annual growth rates, set to expand at a rate of more than 5% in 2020
• Asia-Pacific is emerging as the fastest growing guidewires market. A large proportion of diabetic population in India and China aged between 20 and 79 is stimulating demand for surgical procedures and guidewires in the region
• The Japanese guidewires market demonstrates exponential growth possibilities, attributed to the presence of a large geriatric population pool afflicted with chronic conditions

Guidewires Market: Competitive Landscape

The global guidewires market is characterized by the presence of prominent regional as well as global vendors, making it highly competitive in nature. Principal growth strategies include promotion of inorganic growth, diversification of product portfolios through new product launches, optimization of production costs, technological enhancements and collaboration with other players to broaden geographical presence.

On the collaboration front, Boston Scientific partnered with the Mayo Clinic to set in motion the development of minimally-invasive technologies for urology, neuromodulation, endoscopy, heart rhythm management and interventional cardiology in 2019.

For product launches, Cardiovascular Systems Inc., doled out its Viper Wire Advance Coronary Guidewire which received clearance from the US FDA in October 2019. Earlier in May of the same year, Medtronic unveiled its Telescope Guide Extension Catheter to provide additional backup support and access to distal lesions.

For any Queries Related with the Report, Ask an Analyst:

https://www.futuremarketinsights.com/ask-question/rep-gb-11706

Guidewires Market Taxonomy:

Product Type

Diagnostic Guidewires

• Hydrophilic Guidewires
• Hydrophobic Guidewires

Interventional Guidewires

• Hydrophilic Guidewires
• Hydrophobic Guidewires

Application

• Coronary Guidewires
• Peripheral Guidewires
• Urology Guidewires
• Radiology Guidewires
• Neurovascular Guidewires
• Gastroenterology Guidewires
• Others

Material Type

• Nitinol Guidewires
• PTFE Guidewires
• Stainless Steel Guidewires
• Hybrid Guidewires

Tip Shape

• J Tip
• Angled Tip
• Straight Tip

End User

• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratories
• Specialty Clinics

Region and Country

North America

• U.S.
• Canada

Latin America

• Brazil
• Mexico
• Argentina

Europe

• U.K
• Germany
• Spain
• France
• Italy
• Russia

East Asia

• China
• Japan
• South Korea

South Asia

• India
• ASEAN

Middle East & Africa

• GCC
• North Africa
• Southern Africa
• Rest of MEA

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-11706

Get Valuable Insights into the Guidewires Market

Future Market Insights offers actionable insights and unique perspective on guidewires market in its latest study, presenting historical demand assessment from 2015 – 2019 and projections from 2020–2030 based on product type (interventional guidewires and diagnostic guidewires), by application (coronary guidewires, peripheral guidewires, urology guidewires, radiology guidewires, neurovascular guidewires, gastroenterology guidewires and others) by material type (Nitinol guidewires, PTFE guidewires, stainless steel guidewires and hybrid guidewires) by tip shape (J tip, angled tip and straight tip) by end-user (hospitals, ambulatory surgical centers, cardiac catheterization laboratories and specialty clinics) in seven key regions.

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

According to a thorough analysis, the worldwide home healthcare market growth is anticipated to grow at a CAGR of 3.1% from 2022 to 2030, reaching US$ 4 billion.

Home Healthcare Market Size (2022)	US$ 3.13 Bn
Sales Forecast (2030)	US$ 4 Bn
Global Market Growth Rate (2022 to 2030)	3.1% CAGR
Share of Top 5 Market Players	50%

The cost of hospital stays, together with changing patient needs and technological advancements, are putting tremendous pressure on healthcare systems to rethink how treatment is provided in the future. According to a recent Future Market Insights (FMI) analysis on the global home healthcare market, home-based primary care and hospital-at-home care will continue to make major advancements in the near future.

The global COVID-19 epidemic and changing industry priorities have caused a modest reduction in the usage of home healthcare products and solutions since Q1 2022. Lockdowns across the country, the closing of manufacturing facilities, and significant supply chain changes are all posing obstacles to the development of the home healthcare sector. The market, however, seems poised for a quick recovery after the coronavirus was contained.

For more insights into the market, request a sample of this report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-11594

Key Takeaways of Home Healthcare Market Study

• Prevalence of chronic diseases, especially among the geriatric population, is opening a broad array of opportunities for home healthcare companies.
• Infusion pumps would remain preferred among various home healthcare products such as pressure relief devices; ostomy drainage bags to follow closely.
• Stoma care would be the prominent application area in home healthcare market; key players to invest in IV medication.
• North America and Europe continue to offer opportunities of growth and profitability, owing to strong presence of leading players and rising adoption of home healthcare services.

Leading Manufacturers Capitalize on Product Portfolio Expansion and Distributional Partnerships

A majority of companies are focused on development of innovative home healthcare. Several prominent players are investing in expansion of their product portfolio thorough acquisitions in order to extend their geographical reach. For instance, the famous BD and C.R. Bard merger gave rise to a new global healthcare leader. With an aim to expand operations in the UK, Medline had announced opening of its new warehouse in the UK, in 2018.

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-11594

Some of the prominent players in home healthcare industry that are profiled in the FMI report, include Coloplast A/S, Baxter International Inc, B. Braun Melsungen AG, Hollister Incorporated, ConvaTec Group Plc, Medtronic plc., and Becton Dickinson and Co.

Know More About Report Inclusions

The FMI report brings to fore a comprehensive research on the market growth forecast at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global Home Healthcare market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights on Home Healthcare market on basis of product type (infusion systems, pressure relief devices, hydrocolloid dressings, hydrofibre dressings, hydrogel dressings, semi-permeable film dressings, superabsorbent dressings, wound contact layers, gauze sponges, gauzes, sponges, ostomy drainage bags), application (total parenteral nutrition (TPN), IV medication, pressure ulcer, stoma care), across seven major regions.

Ask for Customization

https://www.futuremarketinsights.com/customization-available/rep-gb-11594

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The medical ventilators market is expanding quickly as more emphasis is being placed on increasing production to meet an unexpected rise in demand during the COVID-19 epidemic. The market for medical ventilators was estimated at US$ 1.2 billion in 2019 and is anticipated to grow at a CAGR of 8.7% over the following five years (2020-2030).

Data Points	Market Insights
Market Value 2021	USD 1.4 Bn
Market Value 2022	USD 1.5 Bn
Market Value 2030	USD 3.1 Bn
CAGR 2022-2030	9.1%
Share of Top 5 Countries	48.8%
Key Players	The key players in medical ventilators market are Becton Dickinson and Company, Cardinal Health, GE Healthcare, Koninklijke Philips N.V., Draegerwerk AG & Co. KGaA, Medtronic Plc., Getinge AB, Hamilton Medical AG, Smiths Medical, Fisher & Paykel Healthcare, and Bunnell Incorporated

The need for medical ventilators has significantly increased due to an increase in the number of severe cases of the life-threatening new coronavirus (COVID-19). During the projected period, manufacturers’ and governments’ intense focus on creating more medical ventilators is anticipated to drive market growth (2020-2030). A substantial opportunity for global medical ventilators market companies to differentiate their goods from the competition is created by the growing need for portable and affordable medical ventilators.

To remain ahead of your competitors, request a sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-11287

Key Takeaways of Medical Ventilators Market Study

• Sales of critical care ventilators contributed the maximum share to the total market value, owing to increasing use in critical care areas of hospitals and other care areas as well.
• Extensive use of invasive ventilators in the management of chronic respiratory failure is expected to result in a notable share of the segment in the medical ventilators market.
• Hospital remains top end user contributing more than 38% of total demand, in line with high-quality clinical care and rising number of respiratory disease patients.
• North America captured notable revenue share of about 30% and is expected to be the most lucrative region for the medical ventilators market during the forecast period.
• Increasing government funding to boost the medical industry growth in Asian countries is expected to drive growth of the medical ventilators market in the region.

Increasing Production Capacity – Imperative Strategy for Market Players

Manufacturers are now focusing on boosting ventilator manufacturing capacity to meet the urgent global demand due to the coronavirus pandemic. For instance, companies such as Medtronic, Koninklijke Philips N.V., GE Healthcare, and Getinge AB are now rapidly increasing their ventilator production by 40%-60%, to supply ventilators in response to the urgent need across the globe confronting COVID-19.

What does the report cover?

Future market insights offer a unique perspective and actionable insights onmedical ventilatorsmarket in its latest study, presenting historical demand assessment from 2015 – 2019 and projections from 2020–2030 based on product (critical care ventilators, and transport ventilators), by technology (invasive ventilators, and non-invasive ventilator), by end user (hospitals and ambulatory surgical centres, long term care centres, and home care settings) in seven key regions.

Get a Tailored Made Report to Match Your requirements, Ask Market Research Expert:

https://www.futuremarketinsights.com/ask-question/rep-gb-11287

MEDICAL VENTILATORS MARKET TAXONOMYFMI’s study on the market offers information divided into four important segments – product type, technology, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product Type

• Critical Care Ventilators
• Transport Ventilators

Technology

• Invasive Ventilators
• Non-Invasive Ventilator

End User

• Hospitals
• Ambulatory Surgical Centers
• Long Term Care Centers
• Home Care Settings

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa

Ask for Customization

https://www.futuremarketinsights.com/customization-available/rep-gb-11287

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

In 2022, the vision care market share will be worth US$83.72 billion. By 2032, the market is projected to be worth US$ 169.37 billion. 7.3% is the predicted CAGR over the forecasted period.

Attributes	Value
Vision Care Market Valuation (2022)	US$ 83.72 billion
Vision Care Market Projected Size (2032)	US$ 169.37 billion
Vision Care Market Anticipated CAGR (2022-2032)	7.3%

The utilization of electronic devices has increased during the last ten years. Our eyes are exposed to the device’s radiation more and more as we spend more time in front of the screen. This then starts to have an impact on our eyes, and we start using different kinds of vision care solutions.

Request Sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-822  

Additionally, the time period we are in makes it difficult for those employed by big corporations to cook meals on their own. They begin eating fast food as a result, which is thought to be unhealthy.

As a result, the eyes are unable to get the nutrition they need. As a result, there is now more demand for products related to eyesight care.

Additionally, there have been significant advancements in logistics and supply chain management, making it possible to ship vision care products anywhere in the world.

The ageing population has, nonetheless, made a considerable contribution to the expansion of the vision care market. Age causes the eye lens to stiffen, which causes various eye issues. Thus, it is anticipated that the demand from the ageing population will raise sales of vision care items.

Additionally, there have been more government and other controlling authority activities to raise awareness of vision care devices.

Key Takeaways:

• The vision care market is expected to grow at a CAGR of 7.3% during the forecast period.
• The vision care market is expected to be valued at US$ 169.37 billion by 2032.
• The vision care market is valued at US$ 83.72 billion as on 2022.
• Based on the product type, the spectacle lens segment is the most preferred segment in the vision care market.
• Based on the type, the non-prescription mode is expected to surge the market for vision care devices.
• Based on the channel, the retail hypermarket/superstore is the most preferred in the vision care market.
• North America is projected to be the largest market based on regional insights.
• Asia Pacific is the second largest, and the fastest growing vision care market.
• Based on country analysis, USA vision care market the largest market, with a share of nearly 34% in North America, and is expected to grow at a CAGR of 7.5% during the forecast period.
• India market is expected to grow at a CAGR of 9.4% during the forecast period.
• Chinese vision care market is anticipated to grow at a CAGR of 7.1%

Talk to Analyst:

https://www.futuremarketinsights.com/ask-question/rep-gb-822   

Competitive Landscape

With a view to increase their footprints across the nations, the major players are getting involved in mergers and acquisitions which would drive their business to new heights.

Some of the recent developments are:

• In July 2022, Bausch and Lomb enrolled first patient in LASIK clinical trial, thereby evaluating the use of Technolas TENEO Excimer Laser for vision correction surgery for hyperobia.
• In February 2022, Johnson and Johnson was named a 2022 Fortune world’s most admired company and ranked #1 on the pharmaceutical industry list.

Key Companies Profiled

• Bausch and Lomb (Acq. by Valeant Pharmaceuticals)
• Alcon (sub. Novartis AG)
• CooperVision
• Johnson & Johnson
• LUXOTTICA GROUP
• Essilor
• ZEISS International
• Safilo Group
• Rodenstock.

Key Segments in the Vision Care Market

By Product Type:

• Spectacle Lenses
• Contact Lenses
• Cleaning & Disinfecting Solutions

By Type:

• Rx (Prescription)
• Non-Rx (Non-prescription)

By Distribution Channel:

• Hospitals
• Ophthalmic Clinics
• Optometry Stores
• E-Commerce
• Retail Hypermarket/Superstore

Ask for Customization

https://www.futuremarketinsights.com/customization-available/rep-gb-822

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

FMI estimates that the global injectable drug delivery market growth is projected at US$ 41.5 Bn in 2022 and is expected to expand at CAGR of 8.9% over 2022–2028, to reach US$ 69.13 Bn by 2028 end. Based on product type, the needle-free injectable drug delivery segment dominated the global injectable drug delivery market in 2017. Moreover, the subtype, prefilled of needle-free injectors segment is expected to have a dominant share of the needle-free type of injectable drug delivery market due to its ease of application. North America is expected to maintain its dominance in the global injectable drug delivery market due to the presence of a large number of manufacturers of injectable drug delivery devices, mostly operating from the U.S.

Attribute	Details
Estimated Injectable Drug Delivery Market Size 2022	US$ 41.5 Bn
Injectable Drug Delivery Market Value-based CAGR (2022-2028)	~8.9%
Projected Injectable Drug Delivery Market Size in 2028	US$ 69.13 Bn

Increase in prevalence of chronic diseases such as diabetes, cancer and rheumatoid arthritis along with other factors such as need for patient-controlled drug release and increased risk of needle stick injuries are the prominent factors expected to drive the growth of the injectable drug delivery market. Technological advancements have resulted in better product offerings in the injectable drug delivery market. However, some factors such as strict regulatory framework and premium pricing of products are expected to hinder the growth of the injectable drug delivery market. The key trend of the injectable drug delivery market is the increasing demand for point-of-care devices. Injectable drug delivery devices are easy to self-administer and do not require a healthcare professional for administration, which as a result skips the need of hospital visits and relatively lowers the healthcare spending for an individual.

The global injectable drug delivery market has been segmented on the basis of product type, usage, end users and regions. The disposable injectable drug delivery segment is expected to be the most attractive usage segment. Among the three end users, the hospital pharmacies is expected to be the dominant segment due to benefits such as favourable reimbursement policies in most of the countries across the globe.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-393

In terms of value, the global injectable drug delivery market is expected to expand at 8.9% CAGR over the forecast period. With nearly 32% market share, North America was a dominant regional market for injectable drug delivery in 2017, due to growing number of manufacturers in the region and early adoption of new technologies. Western Europe is expected to be the second large market in injectable drug delivery, with Germany, the U.K. and France occupying major shares. APEJ is expected to be third large market for injectable drug delivery, due to requirement of low capital for manufacturing injectable drug delivery.

Key Research Findings

• Increase in demand for point-of-care devices and reduced reliance on healthcare facilities are driving the growth of the global injectable drug delivery market
• North America will be the dominant regional market for injectable drug delivery devices due to early adoption of advanced technologies
• Most of the major players operate from the U.S., which makes the U.S. the leading market for injectable drug delivery devices in North America
• In Europe, a large number of diabetes patients are switching towards needle-free injectable drug delivery devices from conventional injections since it is a painless process and reduces the risk of needle stick injuries
• Disposable injectors are the most commonly available type of injectors since they are user friendly and do not require special skills for administration
• Prefilled needle-free injectors are the most preferred type of injectors since they are much easier to administer than the fillable type
• Price control for most of the injectable drug delivery devices is fierce. For instance, Mylan was pressurised to launch the generic version of the EpiPen to reduce the price of the product in the market. However, this has declined the revenue of the company.
• In developed regions, such as North America and Europe, hospitals are the dominant distribution channel due in injectable drug delivery due to the reimbursement policies
• The growing competition in the emerging market and the rising demand for injectable drug delivery are the future opportunities for the growth and expansion of the injectable drug delivery market.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-393

 Key Segments:

Product Type:

• Self-Injectors
• Needle-free Injectors
• Auto-Injectors

Usage:

• Disposable Injectors
• Reusable Injectors

Distribution Channels:

• Hospital Pharmacies
• Retail Pharmacies
• E-commerce

Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East & Africa

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-393

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The demand for cancer diagnostics market forecast is projected to increase as cancer incidence rates rise. According to a Future Market Insights (FMI) report, the market for cancer diagnostics would exceed US$ 47.62 billion in 2021. Cancer will account for approximately 9.9 million deaths in 2020, according to the World Health Organization (WHO), making it the second-leading cause of death worldwide. The demand for better diagnostics has been fueled by an increase in cancer cases.

The global cancer diagnostics market is projected to expand steadily at a CAGR 7.1% value, during the forecast period 2022-2032. In the year 2022, the market size is projected to expand and gain a global market valuation of US$ 191 Billion.

The rise in cancer prevalence, the expansion of government campaigns to raise awareness, the sharp rise in the number of elderly people, technological advancements in a variety of fields, including biopsy, imaging, biomarkers, and endoscopy, as well as rising government funding are the main factors propelling the market for cancer diagnostics.

Appropriate diagnostic techniques are needed to screen the immunosuppressed population, which has a moderate risk of developing cancer, for lung cancer, cervical cancer, breast cancer, prostate cancer, colon cancer, and melanoma, among other cancers. The development of cancer diagnostics is complemented by a rising knowledge of the early warning signs and symptoms of cancer among medical professionals, other healthcare workers, and the general public.

Another significant factor that is anticipated to increase demand for cancer diagnostics is the inclusion of cancer screening tests in National Cancer Screening Programs. Regular mammography has been incorporated into national cancer programmes by significant industrialised nations where the incidence of breast cancer is high, which is driving up the use of cancer diagnostics in developed regions.

For instance, the Nationwide Mammography Program is one of the government of the United States’ national cancer screening programmes. The Australian government is leading the way by implementing three cancer screening programmes, including the National Bowel Cancer Screening Program, BreastScreen Australia, and the National Cervical Screening Program. Similar to this, the majority of European nations are gradually including HPV DNA screening into their national cervical cancer initiatives.

Short-term Negative Impact Likely Due to COVID-19

Due to a decline in cancer diagnosis methods and adoption rates in developed and developing nations, the cancer diagnostics market is anticipated to see short-term negative growth. The world of cancer diagnostics has changed as a result of COVID-19. This has impacted demand on a number of fronts, including logistics and supplies of cancer diagnostic test kits and other important commodities as well as prevention, screening, and diagnosis, palliative care, treatment, and patient follow-up.

Nevertheless, the market is primed to rebound as economies return to normal after a period of sluggish growth. Over 19% of market sales, according to FMI, can be attributed to the increased incidence of lung cancer.

Get Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-1090

Key Takeaways from Cancer Diagnostics Market Study

• The rising incidence of cancer will fuel the demand for cancer diagnostics, enabling the market register 8.5% CAGR between 2021 and 2022
• Increasing cases of cancer in the U.S. accounts for 84% of demand in North America
• Increasing healthcare spending will enable the U.K. market register over 5% y-o-y growth in 2021
• Favorable reimbursement policies will support growth in France and Germany
• Expansion of the healthcare sector will support growth in Japan and South Korea

Who is Winning?

Partnerships between companies that create cancer diagnostic assay kits, make instruments, and licence technologies frequently aim to expand their customer base.

For instance, Illumina, Inc. and Geneseeq Technology Inc. entered into a partnership agreement in March 2021 to create comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer utilising Illumina’s NextSeq 550Dx sequencing platform.

Thermo Fisher Scientific and Daiichi Sankyo agreed to co-launch a companion diagnostic for patients with non-small cell lung cancer that uses the Oncomine Dx target test to identify Her2 gene alterations in June 2020.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-1090

Cancer Diagnostics Market by Category

Test Type

• Tumour Biomarkers Tests
  • PSA Tests
  • CTC Tests
  • AFP Tests
  • CA Tests
  • HER2 Tests
  • BRCA Tests
  • ALK Tests
  • CEA Tests
  • EGFR Mutation Tests
  • KRAS Mutation Tests
  • Others
• Imaging
  • Ultrasound
  • Mammography
  • MRI Scan
  • PET Scan
  • CT Scan
  • SPECT & Others
• Biopsy
  • Needle Biopsy
  • Endoscopic Biopsy
  • Bone Marrow Biopsy
  • Others
• Liquid Biopsy
• Immunohistochemistry
• In Situ Hybridization

Indication

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Melanoma
• Blood Cancer
• Prostate Cancer
• Ovarian Cancer
• Stomach Cancer
• Liver Cancer
• Others

End-user

• Hospital Associated Labs
• Independent Diagnostic Laboratories
• Diagnostic Imaging Centers
• Cancer Research Institutes
• Others

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa (MEA)

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-1090

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

According to Future Market Insights, the pharmaceutical filtration market size is expected to record a robust CAGR of 6.1% for the period from 2017 to 2022.

Active pharmaceutical ingredients are a key component of the pharmaceutical industry in the 21^st century. Filters are essential in a number of cases during the course of API creation and are necessary in bioscience laboratory applications as well. An increased production of large biologics and molecules, nano fibre technological advancements, generic market growth, and regulatory guidelines for cleanroom pharmaceutical production are the main factors driving the pharmaceutical filtration market. Additional funds diverted towards R&D expenditure by major biopharmaceutical organizations also boost the profile of the pharmaceutical filtration market

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-5028

• Manufacturing has the major portion of the revenue share in the pharmaceutical filtration market by operation in 2017 and is likely to remain so throughout the duration of the forecast period. The manufacturing segment is expected to cross a value of more than US$ 9.3 billion by end 2022 making it imperative for companies to be present in this operation segment of the pharmaceutical filtration market. The pilot scale segment follows at a considerable distance but cannot be overlooked entirely in favour of manufacturing. The pilot scale filtration segment has strong scope in North America as the continent represents a little over a third of the pharmaceutical filtration market and is estimated to retain this share going forward
• The cell separation segment comprises slightly above a sixth of the pharmaceutical filtration market by application and is predicted to lose popularity in the future. Nonetheless, the North America cell separation market alone is on track to push past a billion dollars by end 2022 and companies are advised to take this into account while devising their business strategies. The water purification segment has a similar revenue share to the cell separation segment in the pharmaceutical filtration market by application. After North America, the water purification segment is particularly prominent in Europe
• In terms of technology, microfiltration is quite popular as it contributes nearly half the revenue share in the pharmaceutical filtration market in the year 2017. Furthermore, microfiltration is anticipated to witness a high CAGR of more than 5.5% for the period 2017-2022 ensuring that all key stakeholders have ample opportunity in this lucrative technology. Ultrafiltration is not as prominent as microfiltration in the pharmaceutical filtration market but is gaining traction recently. Ultrafiltration technology has the greatest scope in both North America and Europe as these two continents are projected to cross a billion dollars in terms of value by end 2022
• North America is the largest region in the pharmaceutical filtration market and is poised to grow to more than US$ 6 billion by end 2022
• The report has profiled a few of the companies in the pharmaceutical filtration market. These include The Marmon Group LLC, Sartorius Stedim Biotech, Meissner Filtration Products, Parker Hannifin Corporation, Pall Corporation, Merck KGaA, GE Healthcare Inc., Eaton Corporation Plc., Amazon Filters Ltd., and 3M Companies.

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-5028

Key Segments:

Pharmaceutical Filtration Market Taxonomy

Region

• North America
• Latin America
• Europe
• Japan
• APEJ
• MEA

Product Type

• Membrane Filters
• Prefilters and Depth Media Filters
• Single-use Systems
• Cartridge & Capsule Filters
• Filter Holders
• Filtration Accessories
• Other Products

Scale of Operation

• Manufacturing Scale
• Pilot Scale
• R&D Scale
• Application
• Final Product Processing
• Raw Material Filtration
• Cell Separation
• Water Purification
• Air Purification

Technology

• Microfiltration
• Ultrafiltration
• Nanofiltration
• Other techniques

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-5028

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs